Fox Chase Cancer Center: all 215 studies

Page 2 of 3. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.

• Pulse-low-dose Rate (PLDR) Radiation in Pancreatic CancerActive, not recruitingNCT04452357Not applicable
• nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational BronchoscopyStatus unknownNCT04441749
• Phase I Study in Advanced Malignancies With 5-ALASuspendedNCT04381806Phase 1
• Atorvastatin ± Aspirin in Lynch Syndrome SyndromeCompletedNCT04379999Early Phase 1
• Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for MammographyCompletedNCT04290585Not applicable
• Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue SarcomaActive, not recruitingNCT04055753
• Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic StricturesWithdrawnNCT04037072Phase 2
• Utility of CAML as Diagnostic for Early Stage Lung CancerTerminatedNCT03992183
• Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLCActive, not recruitingNCT03786692Phase 2
• Palliative and Oncology Care Intervention: Symptom COACHStatus unknownNCT03760471Not applicable
• Brigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell LymphomaWithdrawnNCT03719898Phase 2
• Organ Preservation in Early Rectal Cancer PatientsActive, not recruitingNCT03548961Phase 2
• Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLCActive, not recruitingNCT03527108Phase 2
• Development of Real-time Image-guided RadiotherapyTerminatedNCT03524248Not applicable
• Molecular Monitoring With Circulating Tumor DNA and Nivolumab MaintenanceCompletedNCT03311958Early Phase 1
• Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle AspirateCompletedNCT03311620Not applicable
• A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial CarcinomaWithdrawnNCT03310567Phase 2
• Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial CarcinomaActive, not recruitingNCT03291028
• VM110 in Detection of Microscopic Tumors: A Phase I StudyTerminatedNCT03286062Phase 1
• Impact of Ribociclib on Head and Neck Squamous Cell CancerTerminatedNCT03179956Early Phase 1
• Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial CarcinomaActive, not recruitingNCT03179943Phase 2
• SMART Project in Preventing Skin CancerCompletedNCT03177057Not applicable
• Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell CarcinomaActive, not recruitingNCT03172754Phase 1/2
• Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast CancerActive, not recruitingNCT03125928Phase 2
• Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Active, not recruitingNCT03114527Phase 2
• Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by SurgeryCompletedNCT03095209
• Improving the Approach to and Management of the Older Metastatic Breast Cancer PatientCompletedNCT03007641Not applicable
• Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the BladderActive, not recruitingNCT02968732Not applicable
• A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast CancerActive, not recruitingNCT02755272Phase 2
• Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)CompletedNCT02710734Phase 2
• A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell LymphomaCompletedNCT02616965Phase 1
• Combination of Interferon-gamma and Nivolumab for Advanced Solid TumorsCompletedNCT02614456Phase 1
• A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple MyelomaCompletedNCT02609230Phase 1
• Perioperative Risk StudyActive, not recruitingNCT02456389Not applicable
• A Biobehavioral Model of Diabetes Risk in Chinese ImmigrantsCompletedNCT02449213
• A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer PatientsCompletedNCT02442323Not applicable
• Smoking Cessation for Low-Income Pregnant WomenCompletedNCT02211430Not applicable
• Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDSCompletedNCT02190695Phase 2
• A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young AdultsCompletedNCT02147080Not applicable
• Comparative Effectiveness of CTC & OCCompletedNCT02143115
• Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationCompletedNCT02132858
• Next Generation Sequence Target-Directed Therapy in Treating Patients With CancerCompletedNCT02132845Not applicable
• Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the LiverTerminatedNCT02110953Phase 1
• Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine TumorsStatus unknownNCT02092714
• PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary CancerCompletedNCT02088775Not applicable
• Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02050009Phase 1
• Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyCompletedNCT01982591
• Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA MenCompletedNCT01937585Not applicable
• Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing ChemotherapyTerminatedNCT01934179
• Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung CancerCompletedNCT01840150Not applicable
• Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryTerminatedNCT01739439Phase 1
• Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareCompletedNCT01726296Not applicable
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
• Facilitating Follow-Up Adherence for Abnormal Pap SmearsCompletedNCT01561326Not applicable
• Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell LymphomaWithdrawnNCT01539174Phase 2
• Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung CancerTerminatedNCT01471964Phase 1/2
• 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent TumorsCompletedNCT01470365Phase 1
• Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community SettingCompletedNCT01440855Not applicable
• Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
• Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
• A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
• Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01059552Phase 1
• Couple-Focused Intervention for Breast Cancer PatientsCompletedNCT00940277Not applicable
• Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing SurgeryCompletedNCT00900016
• Tailored Intervention for Melanoma Patient's FamiliesCompletedNCT00816374Not applicable
• Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate CancerWithdrawnNCT00694291Phase 2
• The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical DysplasiaCompletedNCT00653146Not applicable
• Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced CancerCompletedNCT00604409Phase 1
• Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing ChemotherapyCompletedNCT00509626Phase 1/2
• Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy ParticipantsCompletedNCT00478309Not applicable
• Traditional Print Communication Methods, Simple Electronic Communication Methods, or Usual Care in Increasing How Often Older Women Undergo Colorectal Cancer ScreeningCompletedNCT00459030Not applicable
• Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in ChildrenCompletedNCT00458588
• A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for CancerCompletedNCT00436397Not applicable
• Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the ChestCompletedNCT00433524Not applicable
• Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
• Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal CancerCompletedNCT00352638Phase 3
• Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With ParapsoriasisTerminatedNCT00322296Phase 2
• Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung CancerCompletedNCT00315185Phase 2
• Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic CancerCompletedNCT00244868Phase 3
• Celecoxib in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaCompletedNCT00101335Phase 2
• Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy ParticipantsCompletedNCT00087360Not applicable
• Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00084591Phase 1
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
• Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate CancerWithdrawnNCT00084565Phase 2
• Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast CancerCompletedNCT00084539Phase 2
• Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate CancerCompletedNCT00084526Phase 1/2
• Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing CancerCompletedNCT00084513Phase 1
• Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00062322Phase 1
• Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00062309Phase 3
• Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00062296Phase 2
• Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWithdrawnNCT00054392Phase 3
• Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast CancerWithdrawnNCT00041353Not applicable
• Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00039520Phase 2
• Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00039507Phase 2
• Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney CancerWithdrawnNCT00025519Phase 2
• Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung CancerCompletedNCT00022711Phase 2
• Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00022308Phase 1
• Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal CancerCompletedNCT00021398Phase 2
• Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00021372Phase 2
• Isotretinoin Plus Dexamethasone in Treating Patients With Multiple MyelomaCompletedNCT00021359Phase 2

← Fox Chase Cancer Center overview and focus areas